In this review article, we focus on the role of CD133 as a PCSC marker because of its concrete evidence from an in vivo tumorigenicity assay, its higher specificity due to extremely low levels (<1%) in PC tissues [47,53,54] and its role of stemness maintenance in CSCs. Here, PROM1 is linked to pachyonychia congenita.